BSECompany Update7 Oct 2026 · 7 Oct 2026, 06:30 pm

News Paper Publications

Natco Pharma Ltd · 524816

✦ AI SummaryFundraise

Natco Pharma Ltd has published newspaper notices regarding its forthcoming Rights Issue in Financial Express, Surya, and Janasatta on October 7, 2026, as per Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Analysis Scores

Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Attachments (1)

📄

ca0ab7b2-f26d-4f73-8650-8a7ea844bdd2.pdf

pdf

Download →
View document text
7th October, 2026 Corporate Relationship Department Manager – Listing M/s. BSE Ltd. M/s. National Stock Exchange of India Ltd Mumbai 400 001 Mumbai 400 051 Scrip Code: 524816 Scrip Code: NATCOPHARM Dear Sir / Madam Sub: - Paper Publications Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, please find enclosed the copies of the newspaper Publications as appeared on October 7, 2026 in Financial Express, Surya and Janasatta regarding Notice to the Eligible Equity Shareholders of the Company for the forthcoming Rights Issue. The above publications are available on the website of the Company at www.natcopharma.co.in Thanking you Yours faithfully For NATCO Pharma Limited Ch. Venkat Ramesh Company Secretary & Compliance Officer Encl: as above 7 A¢°fc¶fS, 2026